Skip to content

Clinical trials

Completed Phase 2/3 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 2/3 Status: Completed Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20031
20043
20052
20081
20093
20102
20111
20125
20132
20142
20151
20172
20181
20192
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanabe Pharma Corporation5
Manhattan Psychiatric Center2
Otsuka Pharmaceutical Co., Ltd.2
The University of Hong Kong2
University of Maryland, Baltimore2
Yale University2
Abraham Reichenberg1
Amneal Pharmaceuticals, LLC1
Clinic for Psychiatric Disorders, Dr Laza Lazarevic1
Hospital de Clinicas de Porto Alegre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia34
Psychotic Disorders11
Mental Disorders5
Hallucinations2
Acute Pain1
Affective Disorders, Psychotic1
Bipolar Disorder1
Chronic Pain1
Cognition Disorders1
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.